TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) EGX:RMDA:
EGYPT'S RAMEDA Q1 STANDALONE PROFIT EGP 105.2 MILLION
EGYPT'S RAMEDA Q1 STANDALONE REVENUE EGP 1.05 BILLION
Egypt's Rameda Q1 Standalone Profit EGP 105.2 Million
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda on 6ix
Earlier from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- Rameda FY Consol Profit EGP 313.2 Million
- LVP Pharma Raises Stake In RAMEDA To 23.15% - EGX
- LVP Pharma Raises Stake In RAMEDA To 11.8% - EGX
- Egypt's Rameda Q3 Income EGP 96 Mln
- Egypt's Rameda Borad Proposes To Increase Issued Capital
Later from Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
- Egypt's RAMEDA Appoints Sherif Ahmed Mohamed El Akhdar As Chairman
- LVP Pharma Raises Stake In Egypt's Rameda To 31.498%
- Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) - EGM Minutes
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda into a list and get an email when it puts out news.
Follow Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda